As of 2026-09-08, the Fair Value of Black Diamond Therapeutics Inc (BDTX) is -14.75 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.12 USD, the upside of Black Diamond Therapeutics Inc is -795.83%.
With the market price of 2.12 USD and our fair value calculation, Black Diamond Therapeutics Inc (BDTX) is not a good investment. Investing in BDTX stocks now will result in a potential loss of 795.83%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -125.60 | -91.17 | -82.44 | -69.68 | 22.37 | -69.30 |
| YoY growth | -86.77% | 27.41% | 9.57% | 15.48% | 132.10% | 19.56% |
| Market Cap (mil) | 121.48 |
| P/E | |
| Forward P/E | 7.10x |
| EPS | -0.75 |
| Avg earnings growth rate | 19.56% |
| TTM earnings | -43.21 |